• Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORNAV:FH

28.4100 EUR 0.1400 0.50%

As of 11:30:00 ET on 08/20/2014.

Snapshot for Orion OYJ (ORNAV)

Open: 28.2700 Day's Range: 28.1600 - 28.4400 Volume: 6,361
Previous Close: 28.2700 52wk Range: 17.4100 - 28.4000 1-Yr Rtn: +65.26%

Stock Chart for ORNAV

No chart data available.
  • ORNAV:FH 28.4100
  • 1D
  • 1M
  • 1Y
28.2700
Interactive ORNAV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNAV

Current P/E Ratio (ttm) 19.4589
Estimated P/E(12/2014) 18.9906
Relative P/E vs. HEXP 0.7269
Earnings Per Share (EUR) (ttm) 1.4600
Est. EPS (EUR) (12/2014) 1.4960
Est. PEG Ratio -
Market Cap (M EUR) 4,032.11
Shares Outstanding (M) 41.37
30 Day Average Volume 6,391
Price/Book (mrq) 7.7711
Price/Sale (ttm) 3.9785
Dividend Indicated Gross Yield 4.40%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNAV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNAV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNAV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil